Saturday 17 October 2026
Export NRSN’s income statement to Excel — free account
NeuroSense Therapeutics Ltd.
NRSN Healthcare Biotechnology
Insiders bought in the last twelve months.
3.07
0.10
−3.15%
Follow NRSN
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
0.21 | 3.41 | 2.68 | 7.13 | 11.10 | 0.74 | 0.90 |
Receivables |
0.57 | 0.99 | 0.24 | 0.26 | 0.31 | 0.03 | 0.02 |
Total current assets |
0.78 | 4.40 | 2.92 | 7.38 | 11.41 | 0.77 | 0.91 |
Property, Plant, Equpment (Net) |
0.06 | 0.07 | 0.09 | 0.08 | 0.02 | 0.01 | 0.01 |
Long-Term Investments |
0.02 | 0.02 | 0.02 | 0.02 | — | — | 0.04 |
Total non-current assets |
0.25 | 0.17 | 0.27 | 0.33 | 0.02 | 0.01 | 0.04 |
Total Assets |
1.03 | 4.58 | 3.19 | 7.71 | 11.43 | 0.78 | 0.96 |
Accounts Payable |
0.80 | 1.16 | 1.46 | 0.50 | 0.04 | 0.06 | 0.02 |
Total current liabilities |
2.52 | 1.99 | 3.46 | 1.73 | 0.60 | 0.12 | 0.04 |
Long Term Debt (Total) |
0.07 | — | 0.07 | 0.15 | — | — | — |
Non-current Liabilities (Other) |
— | — | 1.41 | 0.22 | 1.83 | — | — |
Total non-current liabilities |
0.07 | — | 1.49 | 0.37 | 1.83 | — | — |
Total liabilities |
2.59 | 1.99 | 4.94 | 2.09 | 2.43 | 0.12 | 0.04 |
Additional Paid In Capital |
46.23 | 39.24 | 24.36 | 26.41 | 17.45 | 5.06 | 2.50 |
Retained Earnings |
(47.78) | (36.66) | (26.12) | (20.79) | (8.45) | (4.40) | (1.58) |
Common Equity (Total) |
(1.56) | 2.58 | (1.76) | 5.62 | 9.01 | 0.66 | 0.92 |
Shareholders Equity (Total) |
(1.56) | 2.58 | (1.76) | 5.62 | 9.01 | 0.66 | 0.92 |
Shareholders Equity and Liabilities (Total) |
1.03 | 4.58 | 3.19 | 7.71 | 11.43 | 0.78 | 0.96 |
Shares (Common) |
1.63 | 1.16 | 0.77 | 0.59 | 0.55 | 0.28 | 0.26 |
Shareholders Equity (Tangible) |
(1.56) | 2.58 | (1.76) | 5.62 | 9.01 | 0.66 | 0.92 |
Net Debt |
(0.14) | (3.41) | (2.61) | (6.98) | (11.10) | (0.74) | (0.89) |
Total Debt |
0.07 | — | 0.07 | 0.15 | — | — | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Oct 2026